The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Functionalized‐Quantum‐Dot–Liposome Hybrids as Multimodal Nanoparticles for Cancer
Abstract
Functionalized‐quantum‐dot–liposome (f‐QD‐L) hybrid nanoparticles are engineered by encapsulating poly(ethylene glycol)‐coated QD in the internal aqueous phase of different lipid bilayer vesicles. f‐QD‐L maintain the QD fluorescence characteristics as confirmed by fluorescence spectroscopy, agarose gel electrophoresis, and confocal laser scanning microscopy. Cationic f‐QD‐L hybrids lead to dramatic improvements in cellular binding and internalization in tumor‐cell monolayer cultures. Deeper penetration into three‐dimensional multicellular spheroids is obtained for f‐QD‐L by modifying the lipid bilayer characteristics of the hybrid system. f‐QD‐L are injected intratumorally into solid tumor models leading to extensive fluorescent staining of tumor cells compared to injections of the f‐QD alone. f‐QD‐L hybrid nanoparticles constitute a versatile tool for very efficient labeling of cells ex vivo and in vivo, particularly when long‐term imaging and tracking of cells is sought. Moreover, f‐QD‐L offer many opportunities for the development of combinatory therapeutic and imaging (theranostic) modalities by incorporating both drug molecules and QD within the different compartments of a single vesicle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Binding and interstitial penetration of liposomes within avascular tumor spheroids
Kostarelos, K., Emfietzoglou, D., Papakostas, A., Yang, W., Ballangrud, Å., & Sgouros, G. (2004) · International Journal of Cancer · doi:10.1002/ijc.20457 · Cited by 127
Self-citation
Cited by
Designing multifunctional quantum dots for bioimaging, detection, and drug delivery
Zrazhevskiy, P., Sena, M., & Gao, X. (2010) · Chemical Society Reviews · doi:10.1039/b915139g · Cited by 997
Quantum dots: bright and versatile in vitro and in vivo fluorescence imaging biosensors
Wegner, K. D., & Hildebrandt, N. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00532e · Cited by 984
Strategies for the intracellular delivery of nanoparticles
Chou, L. Y. T., Ming, K., & Chan, W. C. W. (2011) · Chem. Soc. Rev. · doi:10.1039/c0cs00003e · Cited by 811
Al-Jamal, W. T., & Kostarelos, K. (2011) · Accounts of Chemical Research · doi:10.1021/ar200105p · Cited by 696
Self-citationSurface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review
Riaz, M., Riaz, M., Zhang, X., Lin, C., Wong, K., Chen, X., Zhang, G., Lu, A., & Yang, Z. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010195 · Cited by 509
Hybrid Nanoparticles for Detection and Treatment of Cancer
Sailor, M. J., & Park, J. (2012) · Advanced Materials · doi:10.1002/adma.201200653 · Cited by 487
Quantum dots as a platform for nanoparticle drug delivery vehicle design
Probst, C. E., Zrazhevskiy, P., Bagalkot, V., & Gao, X. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.036 · Cited by 466
Nanoparticles for biomedical imaging
Nune, S. K., Gunda, P., Thallapally, P. K., Lin, Y.-Y., Laird Forrest, M., & Berkland, C. J. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903229031 · Cited by 450
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals
Ying, X., Wen, H., Lu, W.-L., Du, J., Guo, J., Tian, W., Men, Y., Zhang, Y., Li, R.-J., Yang, T.-Y., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.09.020 · Cited by 447
Liposomal Delivery Systems: Design Optimization and Current Applications
Abu Lila, A. S., & Ishida, T. (2017) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00624 · Cited by 382
Nanoparticle Technologies for Cancer Therapy
Alexis, F., Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_2 · Cited by 364
Berg, J. M., Romoser, A., Banerjee, N., Zebda, R., & Sayes, C. M. (2009) · Nanotoxicology · doi:10.3109/17435390903276941 · Cited by 364
Mahmoud, K. A., Mena, J. A., Male, K. B., Hrapovic, S., Kamen, A., & Luong, J. H. T. (2010) · ACS Applied Materials & Interfaces · doi:10.1021/am1006222 · Cited by 316
Li, Y., He, H., Jia, X., Lu, W.-L., Lou, J., & Wei, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.004 · Cited by 310
Recent Developments of Liposomes as Nanocarriers for Theranostic Applications
Xing, H., Hwang, K., & Lu, Y. (2016) · Theranostics · doi:10.7150/thno.15464 · Cited by 296
Quantum dots, lighting up the research and development of nanomedicine
Wang, Y., & Chen, L. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.12.006 · Cited by 273
Quantum dot-based theranostics
Ho, Y.-P., & Leong, K. W. (2010) · Nanoscale · doi:10.1039/b9nr00178f · Cited by 253
Magnetoliposomes for controlled drug release in the presence of low-frequency magnetic field
Nappini, S., Bombelli, F. B., Bonini, M., Nordèn, B., & Baglioni, P. (2010) · Soft Matter · doi:10.1039/b915651h · Cited by 113
Metadata
- Authors
- Al‐Jamal, W. T., Al‐Jamal, K. T., Bomans, P. H., Frederik, P. M., & Kostarelos, K.
- Venue
- Small
- Publisher
- Wiley
- Published
- 2008-09
- Volume
- 4
- Issue
- 9
- Pages
- 1406-1415
- ISSN
- 1613-6810 (ISSN-L)
- 1613-6829
- OpenAlex
- W2142807103
- Cited by
- 199
- References
- 1
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.